Krebs Biochemicals & Industries Limited

NSE KREBSBIO.NS

Krebs Biochemicals & Industries Limited Dividend Yield on February 07, 2025: 0.00%

Krebs Biochemicals & Industries Limited Dividend Yield is 0.00% on February 07, 2025, a 0.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Krebs Biochemicals & Industries Limited 52-week high Dividend Yield is 0.00% on February 07, 2025, which is 0.00% below the current Dividend Yield.
Krebs Biochemicals & Industries Limited 52-week low Dividend Yield is 0.00% on February 07, 2025, which is 0.00% below the current Dividend Yield.
Krebs Biochemicals & Industries Limited average Dividend Yield for the last 52 weeks is 0.00%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NSE: KREBSBIO.NS

Krebs Biochemicals & Industries Limited

CEO	Mr. Jitendra Rameshchandra Shah
IPO Date	Oct. 27, 2016
Location	India
Headquarters	Maas Heights
Employees	191
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Personal Care Plastics

Description

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.

Key trends

Past 5 years